Back

Atrial fibrillation recurrence prediction after radiofrequency ablation for patients with atrial fibrillation and hypertension using the systemic immune inflammation and left ventricular mass indices

30 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Heart in hypertension Clinical ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Luosha Wang

Lanzhou (China)

5 More presentations in this session

Presentation thumbnail
Left ventricular hypertrophy in the automatic electrocardiogram report and mortality risk
Doctor G. Paixao (Belo Horizonte, BR)
Abstract Slides Video
Presentation thumbnail
Hypertensive heart disease and hypertrophic cardiomyopathy share a similar degree of cardiac energetic impairment
Doctor N. Beyhoff (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Association of subclinical cardiac changes, systolic blood pressure, and cardiovascular outcomes
Doctor A. Cai (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Home blood pressure control status altered the cardiovascular prognosis associated with left ventricular hypertrophy in a Japanese nationwide general practice population: The J-HOP Study
Doctor T. Fujiwara (Shimotsuke, JP)
Abstract Slides Video
Presentation thumbnail
Hypertension and mortality risk in heart failure: a gender-specific analysis of HF subtypes
Doctor V. Copeland (Ramat Gan, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Heart in hypertension

The Event

Event poster

ESC Congress 2025

30 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Session
Echocardiographic imaging in atrial fibrillation and atrial cardiomyopathy
thumbnail
Congress Session
Atrial fibrillation miscellaneous
thumbnail
Congress Session
New insights in catheter ablation of atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources